Charles River Laboratories | CRL - Market Capitalization

Stock Price
150.85
Daily Change
-8.27 -5.20%
Monthly
-14.75%
Yearly
7.01%
Q2 Forecast
147.82

Charles River Laboratories reported $8.07B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 37.86B 3.64B Dec/2025
Align Technology USD 12.28B 1.07B Mar/2026
Bruker USD 6.41B 915M May/2026
Cardinal Health USD 49.72B 894M Mar/2026
Charles River Laboratories USD 9.29B 1.44B May/2026
Cigna USD 70.33B 3.19B Mar/2026
Concord Medical Services Hldg CNY 166.72M 11.49M Apr/2026
CVS Health USD 109.3B 17.26B May/2026
Danaher USD 128.46B 33.24B Mar/2026
Dentsply International USD 2.28B 36M May/2026
Elevance Health USD 64.31B 13.6B Mar/2026
Humana USD 20.82B 9.99B Mar/2026
Illumina USD 17.88B 2.74B Mar/2026
Incyte USD 21.73B 3B May/2026
IQVIA Holdings USD 31.35B 2.72B May/2026
Laboratory Of America USD 21.93B 1.13B Mar/2026
Lakefront Biotherapeutics EUR 1.58B 147.61M May/2026
Lonza CHF 39.68B 980.61M Jun/2025
McKesson USD 99.18B 6.81B May/2026
Merck EUR 52.48B 826.08M May/2026
Mettler Toledo International USD 28.34B 2.8B May/2026
Novartis USD 232.75B 75B May/2026
Pfizer USD 147.4B 6.42B May/2026
Quest Diagnostics USD 21.69B 2.39B Mar/2026
Revvity USD 11.4B 1.46B May/2026
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026
United Therapeutics USD 28.08B 2.9B May/2026
UnitedHealth USD 245.61B 53.42B Mar/2026
Veradigm USD 525M 621M Mar/2026
Waters USD 21.02B 8.84B May/2026
West Pharmaceutical Services USD 18.07B 1.73B Mar/2026